Paul El Tomb

Paul El Tomb practices at Warren Clinic Inc in Tulsa, Oklahoma.

Paul El Tomb's NPI, 1871089243, was assigned on July 9, 2018. Paul El Tomb holds Oklahoma license 38362.

Paul El Tomb's primary practice is Warren Clinic Inc, at 6600 S Yale E Ave, Tulsa, OK 74136 in Tulsa County. The practice phone is (918) 488-6001.

Paul El Tomb's primary practice is Warren Clinic Inc in Tulsa, Oklahoma. Paul El Tomb is also affiliated with Saint Francis Hospital. The medical group on file is Warren Clinic. Dmand AI also links Paul El Tomb to 4 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Paul El Tomb practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Paul El Tomb's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Paul El Tomb is licensed in Oklahoma.

CMS data shows 669 Medicare services from Paul El Tomb across 10 procedure codes in 2024, for 198 Medicare patients. Medicare paid $39,327 for them.

CMS counts 198 Medicare patients who saw Paul El Tomb in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Paul El Tomb's median patient age at 70, with 59% women.

In 2024, Paul El Tomb wrote 298 Medicare Part D claims for 95 patients. 92% of them were for generic drugs. CMS names the drug for 135 of them, across 8 drugs with 11 or more claims each, at $61,688 in total drug cost.

Paul El Tomb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Paul El Tomb as offering telehealth.

Dmand AI links 2 papers to Paul El Tomb in 2023. The most frequent topics are Carcinoma, Hepatocellular, Immune Checkpoint Inhibitors and Immunotherapy. Paul El Tomb's most frequent co-authors are Thomas Urban Marron, MD, PhD, Samuel Shing Kwan Phen, MD and Amit Singal, MD.

CMS Open Payments shows 137 general payments to Paul El Tomb from 28 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 85% of the total. Novartis Pharmaceuticals Corporation paid the most, $408.